Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants-Reference-Cited by-同舟云学术

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants

Published:2018-02-06 Issue:5 Volume:53 Page:605-612
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Blanken Maarten O.¹^ORCID,Paes Bosco²,Anderson Evan J.³,Lanari Marcello⁴,Sheridan-Pereira Margaret⁵,Buchan Scot⁶,Fullarton John R.⁶,Grubb ElizaBeth⁷,Notario Gerard⁸,Rodgers-Gray Barry S.⁶,Carbonell-Estrany Xavier⁹

Affiliation:

1. Division of Pediatric Immunology and Infectious Diseases; University Medical Center Utrecht; Utrecht The Netherlands

2. Neonatal Division, Department of Pediatrics; McMaster University; Hamilton Canada

3. Departments of Pediatrics and Medicine; Emory University School of Medicine; Atlanta Georgia

4. Department of Medical and Surgical Sciences; University of Bologna; Bologna Italy

5. Department of Paediatrics and Newborn Medicine, Coombe Women and Infants University Hospital and Department of Paediatrics; Trinity College; Dublin Ireland

6. Strategen Limited; Basingstoke UK

7. Health Economics and Outcomes Research; AbbVie Inc; North Chicago Illinois

8. Formerly Global Pharmaceutical Research and Development; AbbVie Inc; North Chicago Illinois

9. Neonatology Service, Hospital Clinic; Institut d'Investigacions Biomediques August Pi Suñer (IDIBAPS); Barcelona Spain

Funder

AbbVie

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Reference30 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017